Increase in serum creatinine levels after PARP inhibitor treatment by Di You, Lan Zhong, Rutie Yin, Liang Song

Connect to this object online.

CTNNB1 p.D32A (c.95A > C) somatic mutation in stage I grade 1 endometrioid endometrial carcinoma with lung metastasis: a case report by Lan Zhong, Wei Jiang, RutieYin, Hui Liu, Liang Song

Connect to this object online.

Adverse event profile of albumin-bound paclitaxel: a real-world pharmacovigilance analysis by Yuanqiong Duan, Yuanqiong Duan, Ying Wang, Ying Wang, Shentao Lu, Shentao Lu, Mei Zeng, Mei Zeng, Lubin Liu, Lubin Liu, Qian Dai, Qian Dai, Rutie Yin, Rutie Yin

Connect to this object online.

A comprehensive bibliometric analysis (2000-2022) on the mapping of knowledge regarding immunotherapeutic treatments for advanced, recurrent, or metastatic cervical cancer by Yuanqiong Duan, Yuanqiong Duan, Lin Yang, Lin Yang, Wenxiang Wang, Wenxiang Wang, Peixuan Zhang, Peixuan Zhang, Kaiyu Fu, Kaiyu Fu, Wen Li, Wen Li, Rutie Yin, Rutie Yin

Connect to this object online.

The prognostic factor for recurrence in advanced-stage high-grade serous ovarian cancer after complete clinical remission: a nested case-control study by Qiao Wang, Ying Zheng, Ping Wang, Jiawen Zhang, Hui Liu, Qingli Li, Rutie Yin, Ce Bian, Hongling Peng, Zhilan Peng

Connect to this object online.